Professor Chas Bountra joins 'Science Cities' in Oxford this month
Image: courtesy of the University of Oxford
Future Cities Forum is delighted that Chas Bountra, Pro Vice-Chancellor for Innovation at the University of Oxford, will be contributing to our 'Science Cities' discussion event this January.
He joins Professor Gino Martini, CEO Precision Healthcare Technologies Accelerator (Birmingham Health Innovation Campus / University of Birmingham), and Jim Wilkinson, CFO, Oxford Science Enterprises, on a panel discussion about translating innovation and science discoveries into successful businesses and enterprises that bring benefits for global populations and also local communities for employment and health. We will be asking the question on how can we foster the best cultures for innovation?
Chas is Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology at the University of Oxford. He is also a Visiting Professor in Neuroscience and Mental Health at Imperial College, London.
He is an invited expert on several government and charitable research funding bodies, and an advisor for many academic, biotech and pharma drug discovery programmes.
Chas trained at King’s College London and the University of Edinburgh before taking up a post-doctoral fellowship and college lectureship in Physiology at Oxford.
Prior to returning to Oxford, he worked for 19 years in the pharmaceutical industry, where he was involved in the development of candidate drugs for several diseases, including novel treatments for cancer chemotherapy and IBS. In 2018, he was awarded the “Order of the British Empire” in the New Years Honours list.
Read about Chas’ vision for the future of innovation at Oxford here.
Other contributors taking part in our 'Science Cities' forum will be Nigel Tipple CEO OxLEP, Cllr Ian Courts, Board Director West Midlands Combined Authority, Leader of Solihull Borough Council, Professor Rob Buckingham, Exec. Director, UK Atomic Energy Authority (Culham Campus) and Stuart Grant, CEO ARC Group / CEO Harwell Campus
Commentaires